Cheap blood test detects pancreatic cancer before it spreads

Researchers have developed a blood test using nanosensors to detect pancreatic cancer in its early stages, achieving 73% accuracy in identifying cancer cases and 98% accuracy in identifying healthy individuals. The test detects specific enzymes called proteases that are active in tumors, offering a potential breakthrough for early detection of a disease that claimed 467,000 lives globally in 2022.